Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

453 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of new flu-bu12-tg conditioning with the standard bu-cy myeloablative regimen in patients undergoing allogeneic stem cell transplantation for acute myeloid leukemia.
Raida L, Tucek P, Faber E, Vondrakova J, Rusinakova Z, Skoumalova I, Hubacek J, Jarosova M, Katrincsakova B, Pikalova Z, Kurfurst P, Indrak K. Raida L, et al. Among authors: hubacek j. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Dec;155(4):327-32. doi: 10.5507/bp.2011.040. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011. PMID: 22336644
Spontaneous splenic rupture in a patient with acute promyelocytic leukaemia during induction chemotherapy.
Kuba A, Szotkowski T, Rohon P, Faber E, Turcsanyi P, Hubacek J, Holzerova M, Prasil V, Jarosova M, Indrak K. Kuba A, et al. Among authors: hubacek j. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Jun;159(2):294-8. doi: 10.5507/bp.2013.086. Epub 2013 Nov 26. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015. PMID: 24322341 Free article.
Precursor T-lymphoblastic lymphoma as a secondary malignancy in a young patient after successful treatment of acute promyelocytic leukemia.
Szotkowski T, Jarosova M, Faber E, Hubacek J, Hlusi A, Papajik T, Pikalova Z, Kucerova L, Holzerova M, Budikova M, Buriankova E, Plachy R, Potomkova J, Klusova N, Szotkowska R, Indrak K. Szotkowski T, et al. Among authors: hubacek j. Onkologie. 2009 Sep;32(8-9):513-5. doi: 10.1159/000226584. Epub 2009 Jul 23. Onkologie. 2009. PMID: 19745598
Infectious complications of induction treatment for acute myeloid leukaemia using the "7 + 3" protocol without antibiotic prophylaxis - 15 years of experience of one clinical site.
Cernan M, Szotkowski T, Hubacek J, Kolar M, Faber E, Indrak K, Papajik T. Cernan M, et al. Among authors: hubacek j. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023 Sep;167(3):236-245. doi: 10.5507/bp.2022.010. Epub 2022 Mar 1. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023. PMID: 35258041 Free article.
[Comparison of the effectiveness of idarubicin (Zavedos) and mitoxantrone (Refador) in induction therapy of acute myeloid leukemia in elderly patients (55-75) (a prospective multicenter randomized study conducted 1998-2000].
Indrák K, Hubácek J, Mayer J, Voglová J, Jarosová M, Krahulová M, Malý J, Faber E, Penka M, Kmonícek M, Jebavý L, Szotkowski T, Knotková R, Hlusí A, Zapletalová J. Indrák K, et al. Among authors: hubacek j. Vnitr Lek. 2001 Sep;47 Suppl 1:48-56. Vnitr Lek. 2001. PMID: 11693063 Clinical Trial. Czech.
[Prognostic significance of cytogenetic changes in patients with acute myeloid leukemia (AML). (Analysis of results in 105 patients treated at the Hemato-oncology Clinic of the University Hospital in Olomouc from 1997 to 2000].
Jarosová M, Indrák K, Holzerová M, Hubácek J, Faber E, Papajík T, Raida L, Szotkowski T, Knotková R, Hlusí T, Jedlicková K, Pikalová Z, Sulovská I. Jarosová M, et al. Among authors: hubacek j. Vnitr Lek. 2001 Sep;47 Suppl 1:8-14. Vnitr Lek. 2001. PMID: 11693065 Czech.
453 results